Arlene Campbell

Arlene Campbell is a Precision Oncology Specialist at Guardant Health since May 2019 and has been a Medical Science Liaison account manager at Eurofins Biomnis since August 2017, focusing on oncology education regarding Dihydropyrimidine dehydrogenase deficiency. Prior roles include Medical Science Liaison at OncoDNA and Sales and Business Development Manager at QIAGEN, where responsibilities included marketing the QuantiFERON CMV assay and initiating clinical studies. Arlene has over 20 years of experience in the pharmaceutical industry, previously serving as a Sales and Business Development Manager, contributing innovative solutions in oncology. Additional experience includes positions at Genzyme and Genzyme Europe B.V. as a Medical Science Liaison.